(XTLB) Xtl Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xtl Biopharmaceuticals | (XTLB) share price targets
Complete technical analysis of Xtl Biopharmaceuticals (XTLB) by charts plus indicators, forecast predictions and share price targets for Xtl Biopharmaceuticals (XTLB)
Xtl Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-06-25 View latest technical analysis
10 day averaged volume of Xtl Biopharmaceuticals is 133510
Date | Daily Closing Price | Open | High | Low | Volume |
25 Wed Jun 2025 | 1.20 | 1.21 | 1.25 | 1.14 | 0.285 times |
24 Tue Jun 2025 | 1.31 | 1.11 | 1.72 | 1.02 | 8.744 times |
23 Mon Jun 2025 | 1.02 | 1.15 | 1.15 | 0.86 | 0.256 times |
20 Fri Jun 2025 | 0.95 | 1.24 | 1.30 | 0.93 | 0.142 times |
18 Wed Jun 2025 | 1.22 | 1.15 | 1.26 | 1.15 | 0.01 times |
17 Tue Jun 2025 | 1.17 | 1.19 | 1.28 | 1.14 | 0.066 times |
13 Fri Jun 2025 | 1.12 | 1.23 | 1.39 | 1.05 | 0.497 times |
12 Thu Jun 2025 | 1.20 | 1.17 | 1.20 | 1.17 | 0.097 times |
11 Wed Jun 2025 | 1.19 | 1.20 | 1.20 | 1.19 | 0.061 times |
10 Tue Jun 2025 | 1.20 | 1.23 | 1.23 | 1.20 | 0.012 times |
Share price targets for Xtl Biopharmaceuticals (XTLB)
Target Type | Value |
Downside Target | 0.86 |
Downside Target | 0.92 |
Downside Target | 0.99 |
Downside Target | 1.05 |
Downside Target | 1.10 |
Downside Target | 1.13 |
Downside Target | 1.19 |
Upside Target | 1.25 |
Upside Target | 1.30 |
Upside Target | 1.39 |
Upside Target | 1.54 |
Upside Target | 1.68 |
Upside Target | 1.72 |
Upside Target | 1.74 |
Intraday share price targets for Xtl Biopharmaceuticals (XTLB)
Target Type | Value |
Downside Intraday Target | 0.8 |
Downside Intraday Target | 0.4 |
Upside Intraday Target | 1.66 |
Upside Intraday Target | 2.12 |
Upside Intraday Target | 1.26 |
Weekly technical analysis of Xtl Biopharmaceuticals (XTLB)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Wed Jun 2025 | 1.20 | 1.15 | 1.72 | 0.86 | 42.455 times |
20 Fri Jun 2025 | 0.95 | 1.19 | 1.30 | 0.93 | 0.28 times |
13 Fri Jun 2025 | 1.12 | 1.11 | 1.39 | 1.05 | 8.278 times |
06 Fri Jun 2025 | 1.10 | 1.25 | 1.25 | 1.05 | 0.984 times |
30 Fri May 2025 | 1.20 | 1.13 | 1.25 | 1.10 | 0.516 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Xtl Biopharmaceuticals (XTLB)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Wed Jun 2025 | 1.20 | 1.25 | 1.72 | 0.86 | 6.268 times |
30 Fri May 2025 | 1.20 | 1.47 | 1.74 | 0.99 | 1.292 times |
30 Wed Apr 2025 | 1.41 | 1.17 | 1.68 | 0.92 | 1.517 times |
31 Mon Mar 2025 | 1.20 | 1.37 | 1.54 | 1.13 | 1.295 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Xtl Biopharmaceuticals (XTLB)
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Xtl Biopharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.28 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Xtl Biopharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.28 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.